Levonorgestrel containing intrauterine device (Mirena®) in the treatment of dyfunctional uterine bleeding; patients’ view and our experience

dc.contributor.authorKaramustafaoğlu Balcı, Burçin
dc.contributor.authorHocaoğlu, Meryem
dc.contributor.authorGöynümer, Gökhan
dc.contributor.authorGöçmen, Ahmet
dc.date.accessioned2025-05-10T15:24:33Z
dc.date.issued2016
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractAbnormal uterine bleeding is a common cause for visits to gynecology polyclinics and one of the treatment options is levonorgestrel containing intrauterine device (LNG IUD; Mirena®). The aim of this study is to evaluate patient satisfaction following insertion of Mire-na® in women with the indication of abnormal uterine bleeding and to share our data concerning the use of Mirena. The study population of this retrospective study consisted of women with the diagnosis of dysfuntional abnormal uterine bleeding with Mirena® inserted between 1 January 2015-31 December 2015. Information about age, obstetric and gynecologic history of the patients, histologic diagnosis of endometrial sampling, pelvic ultrasound reports were retrieved from medical records of the patients. Afterwards, interviews on phone were conducted. Patient satisfaction, complications, rate of ame-norrhea, rate of expulsion or displacement, need for removal and if removed the treatment modality preferred were noted. Patient satisfaction was assessed by a scale of four as not satisfied, satisfied, very satisfied and extremely satisfied. A total of 61 Mirena® were inserted during study period and 50 patients were included in the study. We could interview with 31 patients on phone. No complication occurred related to vaginal insertion of Mirena® Twelve patients were ame-norrheic, 4 patients oligomenorrheic, 4 patients were complaining of metrorrhagia (spotting). Displacement of Mirena® did not occur, however in 6.45%. of the patients Mirena® came out accidentally. Four patients wanted their Mirena® to be removed. Eight patients were “not satisfied” at all, the other patients were satisfied from the treatment. As a result, Mirena® was overall a well-tolerated treatment modality and around three-quarter of the patients with Mirena® inserted for the treatment of abnormal uterine bleeding are satisfied from the treatment. © 2016, Logos Medical Publishing. All rights reserved.
dc.identifier.doi10.5222/MMJ.2016.278
dc.identifier.endpage281
dc.identifier.issn2149-2042
dc.identifier.issue4
dc.identifier.scopus2-s2.0-85044162468
dc.identifier.scopusqualityQ2
dc.identifier.startpage278
dc.identifier.trdizinid348642
dc.identifier.urihttps://doi.org/10.5222/MMJ.2016.278
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/348642
dc.identifier.urihttps://hdl.handle.net/20.500.14730/6775
dc.identifier.volume31
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherLogos Medical Publishing
dc.relation.ispartofMedeniyet Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250302
dc.subjectExpulsion; Levonorgestrel- releasing intrauterine device; Mirena®; Satisfaction
dc.titleLevonorgestrel containing intrauterine device (Mirena®) in the treatment of dyfunctional uterine bleeding; patients’ view and our experience
dc.title.alternativeDisfonksiyonel uterin kanamada levonorgestrel içeren rahim içi araç (Mirena®) kullanımı, hastaların memnuniyeti ve deneyimimiz
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
6775.pdf
Boyut:
289.87 KB
Biçim:
Adobe Portable Document Format